(Q42191443)

18 October 2017

title

Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin (English)

1 reference

18 October 2017

0 references

0 references

1 reference

Hyttel J

1

1 reference

18 October 2017

Larsen JJ

series ordinal

2

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 May 1985

1 reference

Journal of Neurochemistry

18 October 2017

published in

1 reference

18 October 2017

volume

44

1 reference

18 October 2017

issue

5

1 reference

18 October 2017

page(s)

1615-1622

1 reference

The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

Peripheral and central muscarinic receptor affinity of psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

Antidepressant drugs affect dopamine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

Inhibition of [3H]dopamine accumulation in rat striatal synaptosomes by psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

An inhibitor of dopamine uptake, LR5182, cis-3-(3,4-dichlorophenyl)-2-n,n-dimethylaminomethyl-bicyclo-[2,2,2]-octane, hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

dl-N-methyl-3-(o-methoxyphenoxy)-3-phenylpropylamine hydrochloride, Lilly 94939, a potent inhibitor for uptake of norepinephrine into rat brain synaptosomes and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1985.TB08803.X

10.1111/J.1471-4159.1985.TB08803.X

21 January 2018

Identifiers

DOI

1 reference

18 October 2017

1 reference